Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor
Clinical trial NCT01037127 · COMPLETED
Trial details
- NCT number
- NCT01037127
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-07-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.